Nuveen Asset Management, LLC Applied Molecular Transport Inc. Transaction History

Nuveen Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.76 - $7.65 $616,611 - $1.71 Million	-223,410 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$5.63 - $13.88 $845,192 - $2.08 Million	150,123 Added 204.84%	223,410 $1.67 Million
Q4 2021 Feb 14, 2022	SELL	$13.23 - $26.05 $83,785 - $164,974	-6,333 Reduced 7.95%	73,287 $988,000
Q3 2021 Nov 12, 2021	SELL	$25.87 - $46.61 $113,103 - $203,778	-4,372 Reduced 5.21%	79,620 $2.19 Million
Q2 2021 Aug 16, 2021	BUY	$39.76 - $64.31 $482,924 - $781,109	12,146 Added 16.91%	83,992 $3.84 Million

Q1 2021 May 17, 2021	BUY	$30.5 - $74.14 $699,914 - $1.7 Million	22,948 Added 46.93%	71,846 $3.16 Million
Q4 2020 Feb 16, 2021	BUY	$29.39 - $35.0 $74,709 - $88,970	2,542 Added 5.48%	48,898 $1.5 Million
Q3 2020 Nov 16, 2020	BUY	$20.49 - $33.58 $949,834 - $1.56 Million	46,356 New	46,356 $1.48 Million

9.42K

Ticker AMTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,900,600
Description
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral and respiratory biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of r...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.